ArticleRespiratory research2026

Genomic characterization of DNA damage response pathway mutations reveals their adverse impact on EGFR-TKI efficacy in non-small cell lung cancer.

Lujie Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.